Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 30 Jun ‘25 |
|
|---|---|---|---|---|---|
| $63.2M | $240M | $177M | 59.9% |
|
|
| $60.8M | $149M | $87.7M | 34.2% |
|
|
| $59.4M | $68M | $8.61M | 109% |
|
|
104
CRISPR Therapeutics
CRSP
$4.96B
| $58.2M | $244M | $186M | 6.33% |
|
| $57.4M | $95.2M | $37.8M | 4.37% |
|
|
| $57.3M | $173M | $115M | 31.7% |
|
|
| $57M | $99.3M | $42.3M | 7.51% |
|
|
| $56.9M | $65.9M | $8.94M | 22.6% |
|
|
| $56.2M | $110M | $54.2M | 34.7% |
|
|
| $56M | $132M | $76.1M | 229% |
|
|
111
ProShares Ultra S&P500
SSO
$5.96B
| $53.5M | $132M | $78.8M | 15.8% |
|
| $52.7M | $72.1M | $19.4M | 55.9% |
|
|
| $52.2M | $63.8M | $11.5M | 5.27% |
|
|
| $52.2M | $52.5M | $274K | 36.4% |
|
|
| $52.1M | $132M | $79.5M | 30% |
|
|
| $52M | $300M | $248M | 20.7% |
|
|
| $51.6M | $201M | $149M | 39% |
|
|
| $51.4M | $144M | $92.8M | 37.9% |
|
|
| $50.7M | $63.5M | $12.8M | 8.9% |
|
|
| $49M | $174M | $125M | 9.46% |
|
|
| $48.5M | $72.2M | $23.6M | 15.1% |
|
|
| $47.6M | $47.6M | $0 | 1.21% |
|
|
| $47.6M | $216M | $168M | 36.1% |
|
|
| $46.3M | $60.2M | $13.9M | 50.4% |
|
|
| $45.9M | $75.9M | $30M | 5.19% |
|